Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
72.04%
0%
72.04%
6 Months
73.59%
0%
73.59%
1 Year
64.32%
0%
64.32%
2 Years
-6.33%
0%
-6.33%
3 Years
51.08%
0%
51.08%
4 Years
-46.69%
0%
-46.69%
5 Years
-67.96%
0%
-67.96%
Beijing Chunlizhengda Medical Instruments Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
17.08%
EBIT Growth (5y)
68.23%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.62
Sales to Capital Employed (avg)
0.41
Tax Ratio
6.13%
Dividend Payout Ratio
40.98%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.42%
ROE (avg)
8.74%
Valuation key factors
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
0.46
EV to EBIT
-6.38
EV to EBITDA
-4.61
EV to Capital Employed
-0.44
EV to Sales
-0.59
PEG Ratio
NA
Dividend Yield
0.91%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
4.11%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY
Mar'25
Mar'24
Change(%)
Net Sales
243.60
239.40
1.75%
Operating Profit (PBDIT) excl Other Income
57.00
65.50
-12.98%
Interest
0.00
0.00
Exceptional Items
1.70
1.50
13.33%
Consolidate Net Profit
62.00
60.00
3.33%
Operating Profit Margin (Excl OI)
234.00%
231.10%
0.29%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2025 is 1.75% vs -14.65% in Mar 2024
Consolidated Net Profit
YoY Growth in quarter ended Mar 2025 is 3.33% vs -6.25% in Mar 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
865.40
1,323.40
-34.61%
Operating Profit (PBDIT) excl Other Income
135.80
323.20
-57.98%
Interest
1.10
0.40
175.00%
Exceptional Items
-4.30
10.60
-140.57%
Consolidate Net Profit
135.20
307.00
-55.96%
Operating Profit Margin (Excl OI)
109.80%
215.30%
-10.55%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -34.61% vs -4.23% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -55.96% vs -14.20% in Dec 2023
About Beijing Chunlizhengda Medical Instruments Co., Ltd. 
Beijing Chunlizhengda Medical Instruments Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






